Acute cardiac care & resuscitationCohort study

Cardiogenic shock in the course of myocardial infarction: the results of the Shock-POL registry

ESC Heart FailPublished

  • snapshot registry
  • 9 cardiology centres across Poland

Authors' conclusion

Short-term mortality rate of AMI-related CS still amounts to 50%, which advocates in favour of further research evaluating the true role of MCS in this population.

Study context

Population
Patients with acute myocardial infarction (AMI)-related cardiogenic shock (CS) hospitalized between January and December 2023
Participants
141 patients
Outcome
In-hospital mortality

Main finding

As reported in the abstract

In-hospital mortality rate

47.5% (n = 67)

Observational data: associations, not effects.

Further findings

Independent predictors of in-hospital mortality (Cox proportional hazards model)

ComparisonEstimate
non-ST-elevation AMIHR 2.38 (95% CI 1.19–4.75)
lack of the need for antibiotic therapyHR 2.61 (95% CI 1.26–5.39)
ageunit HR 1.05 (95% CI 1.02–1.07)
Outcomeunit HR (per 1 mmol/l) (95% CI)
Independent predictors of in-hospital mortality (Cox proportional hazards model) — elevated lactates1.19 (1.11–1.27)

30-day mortality

30-day mortality
51.8% (n = 73)

Society for Cardiovascular Angiography and Interventions class

class C
n = 71, 50.4%
class D
n = 46, 32.6%
class E
n = 24, 17.0%

Revascularization

Percutaneous coronary intervention
133 cases (94.3%)
coronary artery bypass graft
5 (3.5%)

Mechanical circulatory support (MCS)

MCS used
33 patients (23.4%)
intra-aortic balloon pump
n = 26, 18.4%
Impella CP
n = 6, 4.3%
Impella 5.5
n = 2, 1.4%
veno-arterial extracorporeal membrane oxygenation
n = 10, 7.1%

Original publication

Cardiogenic shock in the course of myocardial infarction: the results of the Shock-POL registry. ESC Heart Fail. Published 26 February 2026. doi:10.1093/eschf/xvag066

Summarised from the published abstract; every number is checked against it